CLSL — Crop Life Science Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeMicro CapTurnaround

Annual income statement for Crop Life Science, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,351	1,189	1,020	1,312	1,986
Cost of Revenue
Gross Profit	445	514	426	390	524
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	1,286	1,127	966	1,232	1,892
Operating Profit	65.2	62.2	54.6	80.7	93.9
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	45.9	49.3	37.7	56	81.1
Provision for Income Taxes
Net Income After Taxes	32.3	37	28.1	40.7	60.2
Net Income Before Extraordinary Items
Net Income	32.3	37	28.1	40.7	60.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	32.3	37	28.1	40.7	60.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.88	2.14	1.62	3.39	3.29